CEN Biotech Inc (CENBF)
0.0031
0.00 (0.00%)
USD |
OTCM |
Apr 23, 16:00
CEN Biotech Profit Margin (Quarterly): -426.2% for March 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2023 | -426.2% |
| December 31, 2022 | -157.9% |
| September 30, 2022 | -294.6% |
| June 30, 2022 | -64.20% |
| Date | Value |
|---|---|
| March 31, 2022 | -76.08% |
| December 31, 2021 | -583.2% |
| September 30, 2021 | -264.2% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-583.2%
Minimum
Dec 2021
-64.20%
Maximum
Jun 2022
-266.6%
Average
-264.2%
Median
Sep 2021
Profit Margin (Quarterly) Benchmarks
| Rimrock Gold Corp | -- |
| InMed Pharmaceuticals Inc | -119.2% |
| Venus Concept Inc | -61.31% |
| Juva Life Inc | -85.00% |
| Lucy Scientific Discovery Inc | -27.05K% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -20.66% |
| Return on Invested Capital | -54.77% |
| Operating Margin (Quarterly) | -408.2% |
| Return on Net Operating Assets | -24.94% |